NCT00681486View on ClinicalTrials.gov

Ghrelin - A Possible Opportunity to Improve Appetite

PHASE3CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

June 30, 2008

Study Completion Date

July 31, 2008

Conditions
Cancer
Interventions
DRUG

Ghrelin

High dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

DRUG

Ghrelin

Low dose of ghrelin given as subcutaneous injection once a day for the duration of 8 weeks.

Trial Locations (1)

413 45

Department of surgery, Sahlgrenska University Hospital, Gothenburg

Sponsors

Collaborators (1)

Medical Research Council
All Listed Sponsors
collaborator

Swedish Cancer Foundation

OTHER

collaborator

Medical Research Council

OTHER_GOV

lead

Göteborg University

OTHER

NCT00681486 - Ghrelin - A Possible Opportunity to Improve Appetite | Biotech Hunter | Biotech Hunter